A Study to Investigate the Pharmacokinetic Drug-drug Interaction Following Oral Administration of BI 409306 and Donepezil in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2017
At a glance
- Drugs BI 409306 (Primary) ; Donepezil
- Indications Alzheimer's disease; Cognition disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 15 Apr 2016 Status changed from active, no longer recruiting to completed.
- 24 Feb 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov.
- 19 Jan 2016 Planned End Date changed from 1 Apr 2016 to 1 Mar 2016 as per ClinicalTrials.gov record.